Yes, I think he wants to run the company and build it up. On the other hand he has 4.4m shares, so if someone came in and offered $7 a share I think he would sell. At the more realistic buyout price of $2 a share right now, I seriously doubt he would (I would)
Well I'm sure he would at least entertain the idea, but as of now this theory has only worked in a mice study. If In fact Immunopulse combined with a checkpoint inhibitor increases response rates then OncoSec is looking at a blockbuster therapy and they will be the first to the show. The numbers will be mind boggling and OncoSec will be trading at a level that resembles a major pharma.
News 
Market Data 
Discover 
